Area of research
Nuclear and High Energy Physics · Radiation
Research interest
Research interests include Hepatocellular carcinoma, Sorafenib, Medicine, Biomarker, Cancer research, and Gene knockdown.
The prognostic role of ACSL4 in postoperative adjuvant TACE-treated HCC: implications for therapeutic response and mechanistic insights
Simultaneous treatment with sorafenib and glucose restriction inhibits hepatocellular carcinoma in vitro and in vivo by impairing SIAH1-mediated mitophagy
Identification of Key Genes in Purine Metabolism as Prognostic Biomarker for Hepatocellular Carcinoma
ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma